|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
58,625,000 |
Market
Cap: |
1.61(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$22.72 - $35.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
98,505 |
106,505 |
124,343 |
450,780 |
Total Sell Value |
$3,345,846 |
$3,569,126 |
$4,091,741 |
$15,155,681 |
Total People Sold |
1 |
2 |
5 |
6 |
Total Sell Transactions |
6 |
7 |
11 |
37 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Barris Peter J |
10% Owner |
|
2015-11-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,993,557) |
0 |
|
- |
|
New Enterprise Associates 11 Lp |
10% Owner |
|
2015-11-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,820,625) |
3,820,625 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2015-11-04 |
4 |
AS |
$19.90 |
$99,500 |
D/D |
(5,000) |
102,306 |
|
- |
|
Schwabe Stefan K.f. |
Executive Vice President R&D |
|
2015-07-28 |
4 |
AS |
$21.20 |
$49,827 |
D/D |
(2,350) |
0 |
|
- |
|
Patrick Gregory S |
VP, Chief Financial Officer |
|
2015-07-16 |
4 |
AS |
$20.00 |
$124,340 |
D/D |
(6,217) |
7,344 |
|
- |
|
Schwabe Stefan K.f. |
Executive Vice President R&D |
|
2015-07-13 |
4/A |
AS |
$19.23 |
$37,499 |
D/D |
(1,950) |
2,350 |
|
- |
|
Schwabe Stefan K.f. |
Executive Vice President R&D |
|
2015-07-13 |
4 |
AS |
$19.23 |
$37,499 |
D/D |
(1,950) |
844 |
|
- |
|
Barris Peter J |
10% Owner |
|
2015-06-17 |
4 |
S |
$16.02 |
$781,800 |
I/I |
(48,796) |
0 |
|
- |
|
Barris Peter J |
10% Owner |
|
2015-06-17 |
4 |
S |
$16.67 |
$1,051,804 |
I/I |
(63,085) |
48,796 |
|
- |
|
Baskett Forest |
10% Owner |
|
2015-06-17 |
4 |
S |
$16.02 |
$1,833,603 |
I/I |
(111,881) |
0 |
|
- |
|
Barrett M James |
Director |
|
2015-06-17 |
4 |
S |
$16.02 |
$1,833,603 |
I/I |
(111,881) |
0 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2015-06-17 |
4 |
S |
$16.02 |
$2,254,420 |
I/I |
(136,597) |
0 |
|
- |
|
Barris Peter J |
10% Owner |
|
2015-06-16 |
4 |
S |
$16.85 |
$928,668 |
I/I |
(55,105) |
111,881 |
|
- |
|
Baskett Forest |
10% Owner |
|
2015-06-16 |
4 |
S |
$16.85 |
$1,878,080 |
I/I |
(111,464) |
111,881 |
|
- |
|
Barrett M James |
Director |
|
2015-06-16 |
4 |
S |
$16.85 |
$928,668 |
I/I |
(55,105) |
111,881 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2015-06-16 |
4 |
S |
$16.85 |
$1,614,570 |
I/I |
(95,437) |
111,881 |
|
- |
|
Newhall Charles W III |
Director |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,012 |
26,012 |
|
- |
|
Barris Peter J |
10% Owner |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,162,791 |
166,986 |
|
- |
|
Barris Peter J |
10% Owner |
|
2015-06-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,921,000) |
0 |
|
- |
|
Baskett Forest |
10% Owner |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,144,345 |
166,986 |
|
- |
|
Baskett Forest |
10% Owner |
|
2015-06-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,921,000) |
0 |
|
- |
|
Barrett M James |
Director |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,120,510 |
166,986 |
|
- |
|
Barrett M James |
Director |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,524 |
32,524 |
|
- |
|
Barrett M James |
Director |
|
2015-06-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,921,000) |
921,000 |
|
- |
|
Kolluri Krishna Kittu |
10% Owner |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
930,039 |
9,039 |
|
- |
|
385 Records found
|
|
Page 13 of 16 |
|
|